Stabilized analogs of thymopentin. 1. 4,5-Ketomethylene pseudopeptides

Journal of Medicinal Chemistry

Volumn 40, Issue 15, 1997, Pages 2386-2397

  DeGraw, Joseph I ^a   Almquist, Ronald G ^a   Hiebert, Charles K ^a   Colwell, William T ^a   Crase, Jac ^a   Hayano, Takeshi ^a   Judd, Amrit K ^a   Dousman, Linda ^a   Smith, R Lane ^b   Waud, William R ^c   Uchida, Itsuo ^d  

^a SRI INTERNATIONAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOUTHERN RESEARCH INSTITUTE   (United States)

^d JAPAN TOBACCO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOMODULATING AGENT; PSEUDOPEPTIDE; THYMOPENTIN DERIVATIVE;

ANIMAL CELL; ARTICLE; BINDING COMPETITION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HUMAN; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE; HALF-LIFE; HUMANS; KETONES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; OLIGOPEPTIDES; RADIOLIGAND ASSAY; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; STRUCTURE-ACTIVITY RELATIONSHIP; THYMOPENTIN;

EID: 15444350249     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950803a     Document Type: Article

References (26)

1. Goldstein, G. Isolation of thymopoietin (thymin). Ann. N.Y. Acad. Sci. 1975, 249, 177-185.
2. Schlesinger, D. H.; Goldstein, G. The amino acid sequence of thymopoetin II. Cell 1975, 5, 361-365.
3. Goldstein, G.; Scheid, M.; Bayse, E. A.; Schlesinger, D. H.; Van Wauve, J. A synthetic pentapeptide with biological activity characteristics of the thymic hormone thymopoetin. Science 1979, 204, 1309-1310.
4. DiPerri, T.; Laghi-Pasini, F.; Auteri, A. Immunokinetics of a single dose of thymopoetin pentapeptide. J. Immunopharm. 1980, 2, 567-572.
5. Leung, D. Y.; Hirsch, R. L.; Schneider, C.; Moody, C.; Takaoka, R.; Li, S. H.; Meyerson, L. A.; Mariam, S. G.; Goldstein, G.; Hanifin, J. M. J. Aller. Clin. Immunol. 1990, 85, 927-933.
6. Colle, R.; Ceschia, T.; Colatritto, A.; Biffoni, F. Use of thymopentin in autoimmune hemolytic anemia due to chronic lymphocytic leukemia. Curr. Ther. Res. 1988, 44, 1045-1049.
7. Bernengo, M. G.; Doveil, G. C.; Meregalli, M.; Appino, A.; Massobrio, R. Immunomodulation and Sezary syndrome: experience with thymopentin (TP-5). Br. J. Dermatol. 1988, 119, 207-221.
8. Faist, M.; Ertel, W.; Salmen, B.; Weiler, A.; Ressel, C.; Bolla, K.; Heberer, G. The immune-enhancing effect of perioperative thymopentin administration in elderly patients undergoing major surgery. Arch. Surg. 1988, 123, 1449-1453.
9. Malaise, M. G.; Franchimont, P.; Bach-Anderson, R.; Gerber, H.; Stocker, H.; Hauwaert, C.; Danneskiold-Samsoe, B.; Gross, D.; Gerspacha, H.; Bolla, K. Treatment of active rheumatoid arthritis with slow intravenous injections of thymopentin. Lancet 1985, 832-836.
10. Bodini, G.; Luisa, A.; Solfrini, R.; Marino, M.; Quadri, A. Rheumatoid arthritis: Thymopentin treatment. Curr. Ther. Res. 1991, 50, 189-199.
11. Audhya, T.; Goldstein, G. Thymopentin (TP-5) potency in vivo is enhanced by slow infusion. Int. J. Pept. Protein Res. 1983, 22, 568-572.
12. Clumeck, N.; Vandeperre, P.; Mascartle, F.; Cran, S.; Bolla, K.; Duchateau, J. Preliminary results on clinical and immunological effects of thymopentin in AIDS. Int. J. Clin. Pract. 1985, 4, 455-463.
13. Heavner, G. A.; Audhya, T.; Kroon, D.; Goldstein, G. Structural requirements for the biological activity of thymopentin analogs. Arch. Biochem. Biophys. 1985, 242, 248-255.
14. Audhya, T.; Scheid, M. P.; Goldstein, G. Contrasting biological activities of thymopoetin and splenin, 2 closely related polypeptide products of thumus and spleen. Proc. Natl. Acad. Sci. U.S.A. 1984, 81, 2847-2849.
15. Heavner, G.; Kroon, D.; Audhya, T.; Goldstein, G. Biologically active analogs of thymopentin with enhanced enzymatic stability. Peptides 1986, 7, 1015-1019.
16. Sisto, A.; Mariotti, S.; Groggia, A.; Marcozzi, G.; Villa, L.; Neucioni, L.; Silvestri, S.; Verdini, A.; Pessi, A. Biologically active retro-inverso analogs of thymopentin. Pept.: Chem., Struct. Biol., Proc. Am. Pept. Symp., 11th 1989, 772-773.
17. (a) Almquist, R. G.; Chao, W. R.; Ellis, M. E.; Johnson, H. L. Synthesis and biological activity of a ketomethylene analog of a tripeptide inhibitor of angiotensin converting enzyme. J. Med. Chem. 1980, 23, 1392-1398.
18. (b) Almquist, R. G.; DeGraw, J. I. Oxoalkanoic acid derivatives inhibitory of angiotensin converting enzyme. U.S. Patent 4,329,473, May 11, 1982.
19. Hudson, D.; Sharpe, R.; Szelke, M.; MacIntyre, I.; Fink, G. Physiologically active enkephalin analogs. Br. Pat. Appl. 2,000,-783, 17 Jan, 1979.
20. Parikh, V. M.; Jones, J. K. Oxidation of sugars with ruthenium dioxide-sodium periodate-simple method for the preparation of substituted ketosugars. Can. J. Chem. 1965, 43, 3452-3453.
21. Gibian, H.; Schroeder, E. Peptide synthesis. III. Syntheses of arginine-containing peptides. Ann. 1961, 642, 145-162.
22. Merrifield, R. B. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 1964, 85, 2149-2154.
23. Tischio, T. P.; Patrick, J. E.; Weintraub, H. S.; Chasin, M.; Goldstein, G. Short in vitro half-life of thymopoietin pentapeptide in human plasma. Int. J. Pept. Protein Res. 1983, 14, 479-484.
24. Audhya, T.; Talle, M. A.; Goldstein, G. Thymopoietin radioreceptor assay utilizing lectin-purified glycoprotein from a biologically responsive T-cell line. Arch. Biochem. Biophys. 1984, 234, 167-177.
25. Amoscato, A. A.; Babcock, G. F.; Sramkoski, R. M.; Hynd, B. A.; Alexander, J. W. Synthesis of two biologically active fluorescent probes of thymopentin. Int. J. Pept. Protein Res. 1987, 29, 177-186.
26. Amoscato, A. A.; Balasubramaniam, A.; Alexander, J. W.; Babcock, G. F. Degradation of thymopentin by human lympocytes: evidence for aminopeptidase activity. Biochim. Biophys. Acta 1988, 955, 164-174.